Salicylic Acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of plantar warts located on the bottom of the foot. Plantar warts are characterized by their specific location, tenderness, and disruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and if desired, the wart may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely to ensure proper adhesion of the medicated patch.

If necessary, the medicated patches can be cut to fit the size of the wart. The adhesive side of the patch should then be applied directly onto the wart. To ensure the patch remains in place and to conceal the treated area, it is recommended to cover the patch with additional pads.

This procedure should be repeated every 48 hours as needed, continuing until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on irritated, infected, or reddened skin is prohibited due to the potential for exacerbating the condition.

• The product should not be used on genital warts or warts located on the face, as these areas may require specialized treatment.

• It is contraindicated for use on moles, birthmarks, and warts with hair growing from them, as these may indicate underlying conditions that necessitate caution.

• Application to mucous membranes is not advised, given the risk of irritation and adverse reactions.

Warnings and Precautions

For external use only. This product is contraindicated for application on irritated, infected, or reddened skin. It should not be used on genital warts, warts located on the face, moles, birthmarks, or warts with hair growing from them. Additionally, the product is not intended for use on mucous membranes.

It is imperative to keep this and all medications out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Healthcare professionals should advise patients to seek medical attention if discomfort persists after application. Consultation with a physician or podiatrist is recommended in such cases to ensure appropriate management and care.

Side Effects

Patients should be aware that the product is for external use only. It is contraindicated for use on irritated, infected, or reddened skin, as well as on genital warts, warts on the face, moles, birthmarks, and warts with hair growing from them. Additionally, it should not be applied to mucous membranes.

It is crucial to keep this and all medications out of the reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

If discomfort persists after application, patients are advised to consult their doctor or podiatrist for further evaluation and management.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (medicated plantar wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this and all medications out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The safety of Salicylic Acid during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in this population. Consequently, healthcare professionals should exercise caution when considering the administration of Salicylic Acid to pregnant patients. Due to the lack of available safety data, the potential risks to fetal outcomes remain unclear. It is advisable for women of childbearing potential to discuss their treatment options with their healthcare provider to ensure that any medication used during pregnancy is appropriate and necessary.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution and consider the overall clinical context when prescribing this medication to patients with hepatic impairment, as individual responses may vary.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment of the patient's condition is essential.

Management procedures should include monitoring vital signs and providing supportive care as needed. In cases where the specific substance is known, appropriate antidotes or treatments should be administered as per established protocols.

It is vital for healthcare providers to remain vigilant and act swiftly to mitigate the potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this medication and all other drugs out of the reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that this medication should not be applied to irritated, infected, or reddened skin. It is also important to emphasize that the medication is not intended for use on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, patients should be cautioned against using the medication on mucous membranes.

If patients experience persistent discomfort after using the medication, they should be encouraged to consult their doctor or podiatrist for further evaluation and guidance.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within the temperature range of 15° to 30°F (59° to 86°F) to ensure its stability and efficacy. Proper storage conditions must be maintained, and the product should be kept in its original container to protect it from environmental factors. Special handling precautions should be observed to prevent exposure to temperatures outside the specified range.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)